Imperial College London
Alternate

DrRichardSzydlo

Faculty of Medicine, Department of Immunology and Inflammation

Medical Statistician
 
 
 
//

Contact

 

+44 (0)20 3313 2170r.szydlo Website

 
 
//

Location

 

4N7Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Dominy:2022:10.1182/blood-2022-170375,
author = {Dominy, K and Salmon, M and Szydlo, R and Hayden, C and White, HE and Alikian, M and Milojkovic, D and Copland, M and Foroni, L and Cross, NCP and Clark, RE and Apperley, JF},
doi = {10.1182/blood-2022-170375},
pages = {9631--9632},
publisher = {AMER SOC HEMATOLOGY},
title = {Digital Droplet (dd) Polymerase Chain Reaction (PCR) Assays Offer Limited Advantages over Conventional Reverse-Transcriptase Quantitative PCR (RT-qPCR) for the Prediction of Molecular Recurrence after Treatment Discontinuation in Chronic Myeloid Leukemia (CML): Results from the Destiny Study},
url = {http://dx.doi.org/10.1182/blood-2022-170375},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Dominy,K
AU  - Salmon,M
AU  - Szydlo,R
AU  - Hayden,C
AU  - White,HE
AU  - Alikian,M
AU  - Milojkovic,D
AU  - Copland,M
AU  - Foroni,L
AU  - Cross,NCP
AU  - Clark,RE
AU  - Apperley,JF
DO  - 10.1182/blood-2022-170375
EP  - 9632
PB  - AMER SOC HEMATOLOGY
PY  - 2022///
SN  - 0006-4971
SP  - 9631
TI  - Digital Droplet (dd) Polymerase Chain Reaction (PCR) Assays Offer Limited Advantages over Conventional Reverse-Transcriptase Quantitative PCR (RT-qPCR) for the Prediction of Molecular Recurrence after Treatment Discontinuation in Chronic Myeloid Leukemia (CML): Results from the Destiny Study
UR  - http://dx.doi.org/10.1182/blood-2022-170375
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000893230302277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download